Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00169650 · ClinicalTrials.gov registry record

Laparoscopic Pyeloplasty Registry and Database

A clinical trial of Ureteral Obstruction, sponsored by Indiana Kidney Stone Institute.

Completed
Registry status
64
Enrollment target
1
Study location

NCT00169650 is a study of Ureteral Obstruction that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00169650, a study of Ureteral Obstruction, has completed, sponsored by Indiana Kidney Stone Institute.

COMPLETED
Registry status
64 participants
Enrollment target
1
Study location

Study Summary

The gold standard for the treatment of ureteropelvic junction obstruction (UPJO) is the open pyeloplasty. As a minimally invasive alternative, many centers are currently offering laparoscopic pyeloplasty (LP) as primary therapy for UPJOs. Recent data has shown that laparoscopic pyeloplasty has comparable success rates to open pyeloplasties and produces durable results. The researchers are compiling a registry and database to review outcomes of laparoscopic pyeloplasty patients.

Conditions Studied

Interventions

  • OTHER Registry and database

Study Locations (1)

Indiana

  • IU Health Methodist Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2003-07
Est. Completion 2016-12

Sponsor

Indiana Kidney Stone Institute

16 total trials

What the Registry Record Tells You About NCT00169650

The ClinicalTrials.gov registry entry for NCT00169650 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana Kidney Stone Institute, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ureteral Obstruction appearing as the primary indexed condition, and to 1 intervention - of which Registry and database is the first listed.

NCT00169650 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT00169650 about?

NCT00169650 is a clinical study titled "Laparoscopic Pyeloplasty Registry and Database". The gold standard for the treatment of ureteropelvic junction obstruction (UPJO) is the open pyeloplasty. As a minimally invasive alternative, many centers are currently offering laparoscopic pyeloplasty (LP) as primary therapy for UPJOs. Recent data has shown that laparoscopic pyeloplasty has compa...

What is the current status of trial NCT00169650?

This trial is currently completed. The enrollment target is 64 participants. The study started on 2003-07. Estimated completion is 2016-12.

What conditions does trial NCT00169650 study?

This clinical trial studies the following conditions: Ureteral Obstruction.

What interventions are being tested in trial NCT00169650?

The interventions under investigation include: Registry and database (OTHER).

Who is sponsoring clinical trial NCT00169650?

This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00169650 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ureteral Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.